Read-onlySigned in as demo@nsight.app
As of 10 Oct 2026 · demonstration dates

Portfolio reports show the current active book. Closed and archived borrowers, including their history, are available in All Borrowers.

BluePeak Healthcare Solutions

Healthcare — Physician Practice Management

Portfolio: Active

Selected-quarter financials received. Status, position terms and analyst notes reflect current records.

LTM financial analysis — unadjusted

Unavailable — four consecutive financial quarters are required. Missing: Q1 2025, Q2 2025.

Analyst status: Watch📍 Nashville, TN📅 2024-01-10🏢 Harrowmere Health PartnersWatch list
3 covenants not tested, credit mark 99% of par

Analyst notes

Platform providing management services to dermatology and med-spa physician practices across the Southeast, with 14 locations.
Covenant-tight: Interest Coverage at 1.14x in Q1 (threshold 1.10x)
Q1 EBITDA miss vs. threshold ($4.0M vs $4.5M — waiver obtained)

Positions

InstrumentCommitmentRateFloorMaturityPIKFV Q3 2025FV Q4 2025
Unitranche$22.0MSOFR + 6251%2029-01-10—$21.5M$21.8M

Income Statement Spread ($M)

Line ItemQ3 2025Q4 2025Δ QoQ
Revenue28.430.2↑ 6.3%
COGS(17.0)(18.3)↑ 7.6%
Gross Profit11.411.9↑ 4.4%
Gross Margin %40.1%39.4%↓ 1.8%
SG&A(6.0)(6.3)↑ 4.3%
EBITDA5.45.6↑ 4.5%
EBITDA Margin %18.9%18.6%↓ 1.8%
D&A(1.4)(1.5)↑ 7.1%
Interest Expense(3.6)(3.5)↓ 1.5%
Tax(0.2)(0.3)↑ 50.0%
Net Income0.20.3↑ 52.5%

Balance Sheet ($M)

ItemQ3 2025Q4 2025Δ QoQ
Total Assets126.8128.2↑ 1.2%
Total Debt96.896.9→ 0.1%
Cash2.12.8↑ 33.3%
Equity12.814.5↑ 13.3%

LTM Credit Metrics — unadjusted

Four consecutive quarters of EBITDA and interest; debt is the ending balance. Incomplete history is unavailable. These are analytical ratios, not covenant certificate results.

MetricQ3 2025Q4 2025
LTM leverage (unadjusted)——
LTM interest coverage (unadjusted)——

Submission evidence

Periods without a separate retained submission: Q3 2025, Q4 2025. Earlier financials may be supporting history within an initial upload.

Covenant Compliance

Interest Coverage

Not tested

Not verified · Not independently verified

Actual
Unavailable
Reported
Not supplied
Governing threshold
≥ 1.4x
Reconciliation
Unable to verify
Review
Not reviewed · Needs review

No supplied actual for this quarter.

Minimum LTM EBITDA ($M)

Not tested

Not verified · Not independently verified

Actual
Unavailable
Reported
Not supplied
Governing threshold
≥ $21M
Reconciliation
Unable to verify
Review
Not reviewed · Needs review

No supplied actual for this quarter.

Total Leverage

Not tested

Not verified · Not independently verified

Actual
Unavailable
Reported
Not supplied
Governing threshold
≤ 5x
Reconciliation
Unable to verify
Review
Not reviewed · Needs review

No supplied actual for this quarter.

Fair Value History

Q3 2025
$21.5M
98% of par
Q4 2025
$21.8M
99% of par